In the original version of this article (1), “FGFR4” was incorrectly spelled as “FGF4” in the title, and “FGFR4” and “FGF19” were incorrectly spelled as “FGF4” and “FGFR19” in the Summary and the section titled “Acquired Resistance Paradigm in FGFR4, and Next Steps.” The latest online HTML and PDF versions of the article have been corrected. The authors and publisher regret the error.
References
1.
Subbiah
V
, Pal
SK
. Precision oncology for hepatocellular cancer: slivering the liver by FGF19–FGFR4–KLB pathway inhibition
. Cancer Discov
2019
;9
:1646
–9
.©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.